24,492 research outputs found

    Replication Data for: A Structural Model for the Coevolution of Networks and Behavior

    No full text
    Hsieh, Chih-Sheng, König, Michael D., and Liu, Xiaodong, (2022) “A Structural Model for the Coevolution of Networks and Behavior.” Review of Economics and Statistics 104:2, 355–367

    Structure and bioactivity of the polysaccharides in medicinal plant Dendrobium huoshanense

    No full text
    Abstract not availableYves S.-Y. Hsieh, Cheng Chien, Sylvian K.-S. Liao, Shih-Fen Liao, Wei-Ting Hung, Wen-Bin Yang, Chih-Chien Lin, Ting-Jen Rachel Cheng, Chia-Chuan Chang, Jim-Min Fang and Chi-Huey Won

    Supplemental Material - Morin hydrate suppresses lipoteichoic acid-induced oxidative stress-mediated inflammatory events in macrophages via augmenting Nrf2/HO-1 and antioxidant defense molecules

    No full text
    Supplemental Material for Morin hydrate suppresses lipoteichoic acid-induced oxidative stress-mediated inflammatory events in macrophages via augmenting Nrf2/HO-1 and antioxidant defense molecules by Cheng-Ying Hsieh, Thanasekaran Jayakumar, Kao-Chang Lin, Ting-Lin Yen, Chih-Wei Hsia, Wei-Chieh Huang, Joen-Rong Sheu, and Chih-Hsuan Hsia in European Journal of Inflammation.</p

    Supplementary Material

    No full text
    Supplemental material, Supplementary_Figure-1_submission_TAH for Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study by Ching-Yuan Kuo, Po-Nan Wang, Wen-Li Hwang, Cheng-Hwai Tzeng, Li-Yaun Bai, Jih-Luh Tang, Ming-Chih Chang, Sheng-Fung Lin, Tsai-Yun Chen, Yeu-Chin Chen, Tran-Der Tan, Chih-Yi Hsieh, Chinjune Lin, Clinton Lai, Darko Miljkovic and Cheng-Shyong Chang in Therapeutic Advances in Hematology</p

    Supplementary Material

    No full text
    Supplemental material, Supplementary_Table_1_submission_TAH for Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study by Ching-Yuan Kuo, Po-Nan Wang, Wen-Li Hwang, Cheng-Hwai Tzeng, Li-Yaun Bai, Jih-Luh Tang, Ming-Chih Chang, Sheng-Fung Lin, Tsai-Yun Chen, Yeu-Chin Chen, Tran-Der Tan, Chih-Yi Hsieh, Chinjune Lin, Clinton Lai, Darko Miljkovic and Cheng-Shyong Chang in Therapeutic Advances in Hematology</p

    sj-docx-1-tam-10.1177_17588359231221907 – Supplemental material for Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study

    No full text
    Supplemental material, sj-docx-1-tam-10.1177_17588359231221907 for Major adverse cardiovascular events in advanced-stage lung cancer: a multicenter cohort study by Chih-Hao Chang, Shih-Hao Huang, Hung-Yu Huang, Meng-Hung Lin, Chung-Shu Lee, Hsin-Fu Lee, Jason Chia-Hsun Hsieh and Chun-Yu Cheng in Therapeutic Advances in Medical Oncology</p

    Press Release (1963-06-03) Cheng Hsieh among teachers attending National Science Foundation Institute

    No full text
    University of Minnesota, Duluth. News Service. (1963). Press Release (1963-06-03) Cheng Hsieh among teachers attending National Science Foundation Institute. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/195082
    corecore